Table 2.
Syncarpic acid/β-triketones-based meroterpenes.
| Compounds | Source | Anticancer | Ref. |
|---|---|---|---|
| (−)-Baeckfrutone B (125) | Baeckea frutescens | Cytotoxic effects: DU145 = IC50 79.45 μM | [58] |
| (+)-Baeckfrutone C (126) | Baeckea frutescens | Cytotoxic effects: HCT116 = IC50 62.64 μM; Hela = IC50 85.79 μM; DU145 = IC50 17.65 μM; A549 = IC50 86.68 μM | [58] |
| (−)-Baeckfrutone C (126) | Baeckea frutescens | Cytotoxic effects: HCT116 = IC50 49.09 μM; Hela = IC50 91.22 μM; DU145 = IC50 15.85 μM; A549 = IC50 86.62 μM | [58] |
| Baeckfrutone D (127) | Baeckea frutescens | Cytotoxic effects: HCT116 = IC50 38.32 μM; Hela = IC50 83.85 μM; DU145 = IC50 6.46 μM; A549 = IC50 76.47 μM | [58] |
| Baeckfrutone F (129) | Baeckea frutescens | Cytotoxic effects: HCT116 = IC50 39.5 μM; DU145 = IC50 80.72 μM; A549 = IC50 15.61 μM; Anti-inflammatory effects: 74.4% | [58] |
| Baeckfrutone G (130) | Baeckea frutescens | Cytotoxic effects: HCT116 = IC50 49.76 μM; Hela = IC50 31.87 μM; DU145 = IC50 17.40 μM; A549 = IC50 62.64 μM; Anti-inflammatory effects: 75.3% | [58] |
| Baeckfrutone H (131) | Baeckea frutescens | Cytotoxic effects: HCT116 = IC50 19.50 μM; Hela = IC50 30.44 μM; DU145 = IC50 25.14 μM; A549 = IC50 82.75 μM; Anti-inflammatory effects: 55.1% | [58] |
| Baeckfrutone I (132) | Baeckea frutescens | Cytotoxic effects: HCT116 = IC50 19.50 μM; Hela = IC50 53.71 μM; DU145 = IC50 26.11 μM; A549 = IC50 84.13 μM; Anti-inflammatory effects: 75% | [58] |
| Baeckfrutone J (133) | Baeckea frutescens | Cytotoxic effects: HCT116 = IC50 52.93 μM; DU145 = IC50 4.04 μM; A549 = IC50 79.45 μM | [58] |
| Baeckfrutone K (134) | Baeckea frutescens | Cytotoxic effects: HCT116 = IC50 12.89 μM; DU145 = IC50 77.06 μM; A549 = IC50 80.11 μM | [58] |
| Baeckfrutone L (135) | Baeckea frutescens | Cytotoxic effects: HCT116 = IC50 16.48 μM; Hela = IC50 19.81 μM; DU145 = IC50 10.0 μM; A549 = IC50 88.81 μM | [58] |
| Hyperjaponol H (143) | Hypericum japonicum | Antiviral effects: EBV = EC50 25.0 μM | [61] |
| Tomentosenol A (144) | Rhodomyrtus tomentosa | Cytotoxic effects: MCF-7 = IC50 8.66 μM; NCI-H460 = IC50 8.62 μM; SF-268 = IC50 10.01 μM; HepG-2 = IC50 9.44 μM | [61] |
| Myrtucommulone (147) | Myrtus communis | Cytotoxic effects: HepG2 = IC50 4.39 μM; MDA-MB-231 = IC50 19.92 μM | [62] |
| Myrtucommulone (148) | Myrtus communis | Cytotoxic effects: HepG2 = IC50 40.7 μM; MDA-MB-231 = IC50 40.0 μM | [62] |
| Frutescone A (151) | Baeckea frutescens | Cytotoxic effects: Caco-2 = IC50 8.08; A549 = IC50 20.07 µM | [64] |
| Frutescone B (152) | Baeckea frutescens | Cytotoxic effects: Caco-2 = IC50 23.25 µM; A549 = IC50 41.33 µM | [64] |
| Frutescone C (153) | Baeckea frutescens | Cytotoxic effects: Caco-2 = IC50 14.83 µM; A549 = IC50 27.74 µM | [64] |
| Frutescone D (154) | Baeckea frutescens | Cytotoxic effects: Caco-2 = IC50 10.20 µM; A549 = IC50 26.25 µM | [64] |
| Frutescone E (155) | Baeckea frutescens | Cytotoxic effects: Caco-2 = IC50 7.96 µM; A549 = IC50 5.55 µM | [64] |
| Frutescone F (156) | Baeckea frutescens | Cytotoxic effects: Caco-2 = IC50 16.51 µM; A549 = IC50 39.02 µM | [64] |
| (±)-Frutescone G (157) | Baeckea frutescens | Cytotoxic effects: Caco-2 = IC50 14.31 µM; A549 = IC50 25.71 µM | [64] |
| Callisalignene G (174) | Callistemon salignus | Cytotoxic effects: HCT116 = IC50 8.51 μM; A549 = IC50 12.85 μM | [67] |
| Callisalignene H (175) | Callistemon salignus | Cytotoxic effects: HCT116 = IC50 9.12 μM | [67] |
| Callisalignene I (176) | Callistemon salignus | Cytotoxic effects: HCT116 = IC50 16.33 μM; A549 = IC50 10.03 μM | [67] |
| Frutescone I (178) | Baeckea frutescens | Anti-inflammatory effects: NO production = IC50 18.75 μM | [68] |
| Frutescone L (179) | Baeckea frutescens | Anti-inflammatory effects: NO production = IC50 30.54 μM | [68] |
| Frutescone M (180) | Baeckea frutescens | Anti-inflammatory effects: NO production = IC50 15.17 μM | [68] |
| (±)-Compound (181) | Baeckea frutescens | Anti-inflammatory effects: NO production = IC50 1.80 μM | [68] |
| Compound (182) | Baeckea frutescens | Anti-inflammatory effects: NO production = IC50 0.36 μM | [68] |
| Compound (183) | Baeckea frutescens | Anti-inflammatory effects: NO production = IC50 3.70 μM | [68] |
| (±)-Compound (184) | Baeckea frutescens | Anti-inflammatory effects: NO production = IC50 2.07 μM | [68] |
| (±)-Compound (185) | Baeckea frutescens | Anti-inflammatory effects: NO production = IC50 6.50 μM | [68] |
| Baefrutone A (188) | Baeckea frutescens | Anti-inflammatory effects: NO Production = IC50 9.15 μM | [69] |
| Baefrutone B (189) | Baeckea frutescens | Anti-inflammatory effects: NO Production = IC50 17.73 μM | [69] |
| Baefrutone C (190) | Baeckea frutescens | Anti-inflammatory effects: NO Production = IC50 11.62 μM | [69] |
| Baefrutone D (191) | Baeckea frutescens | Anti-inflammatory effects: NO Production = IC50 18.04 μM | [69] |
| hyperjaponols A (194a) | Hypericum japonicum | Antiviral effects: EBV = EC50 10.33 μM | [70] |
| Hyperjaponol B (195a) | Hypericum japonicum | Antiviral effects: EBV = EC50 0.57 μM | [70] |
| Hyperjaponol B (195b) | Hypericum japonicum | Antiviral effects: EBV = EC50 6.60 μM | [70] |
| Hyperjaponol D (197) | Hypericum japonicum | Antiviral effects: EBV = EC50 0.49 μM | [70] |